REGEnLIFE
About:
MedTech company focused on neurodegenerative diseases
Website: https://regenlife.com
Twitter/X: regenlife1
Description:
REGEnLIFE develops a cutting-edge photomedical neurotechnology for the treatment of neurodegenerative diseases. REGEnLIFE is a late-stage medical technology company currently focused on the treatment of Alzheimer's disease and mild traumatic brain injury (which can lead to dementia). The medical device is a patented therapeutic solution based on biophotonics. This non-invasive and painless application targets both the brain and the gut. Recent scientific studies suggest that the brain-gut axis plays a key role in the development of neurodegenerative diseases.
8.3M EUR
Paris, Ile-de-France, France
2016-01-19
contact(AT)regenlife.com
Guillaume Blivet
1-10
2023-05-12
Private
© 2025 bioDAO.ai